Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1975 Feb 15;1(5954):371–373. doi: 10.1136/bmj.1.5954.371

Ultrasound monitoring of hepatic metastases during chemotherapy.

E D Gilby, K J Taylor
PMCID: PMC1672318  PMID: 163662

Abstract

Grey-scale ultrasonography has been found to be the most sensitive method of detecting metastatic disease of the liver. In two cases the results of chemotherapy were monitored by ultrasound; the response to treatment could be distinguished from non-response and ultrasonography gave useful information when chemotherapy made radioisotope examination unreliable.

Full text

PDF
371

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kossoff G. Improved techniques in ultrasonic cross sectional echography. Ultrasonics. 1972 Sep;10(5):221–227. doi: 10.1016/0041-624x(72)90296-x. [DOI] [PubMed] [Google Scholar]
  2. McElwain T. J., Peckham M. J. Combination chemotherapy for testicular tumours. Proc R Soc Med. 1974 Apr;67(4):297–300. doi: 10.1177/003591577406700442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Rasmussen S. N. Liver volume determination by ultrasonic scanning. Br J Radiol. 1972 Aug;45(536):579–585. doi: 10.1259/0007-1285-45-536-579. [DOI] [PubMed] [Google Scholar]
  4. Taylor K. J., Carpenter D. A., McCready V. R. Grey scale echography in the diagnosis of intrahepatic disease. J Clin Ultrasound. 1973 Dec;1(4):284–287. doi: 10.1002/jcu.1870010403. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES